Vietnam Insulin Infusion Pump Market Size (2024 - 2029)

Vietnam Insulin Infusion Pump Market Analysis

The Vietnam Insulin Infusion Pump Market size is estimated at USD 1.14 million in 2024, and is expected to reach USD 1.46 million by 2029, growing at a CAGR of 5.04% during the forecast period (2024-2029).

Vietnam effectively prevented the spread of the COVID-19 pandemic from the beginning, initially with no deaths reported. However, Vietnam faced a devastating fourth wave of COVID-19 outbreaks. According to the Ministry of Health (MOH), the country experienced four COVID-19 infections. COVID-19, or coronavirus, is a highly contagious viral infection caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Individuals with diabetes were at a higher risk of severe outcomes and mortality from COVID-19. People with diabetes have increased susceptibility to infections due to hyperglycemia, impaired immune function, vascular issues, and comorbidities like hypertension, dyslipidemia, and cardiovascular disease.

In addition, it is important to note that angiotensin-converting enzyme 2 (ACE2) acts as a receptor for the human SARS-CoV-2 virus. As a result, angiotensin-converting enzyme (ACE) inhibitors should be approached with caution in individuals with diabetes. It was observed that the severity and mortality rates of COVID-19 were significantly higher in patients with diabetes than those without diabetes.

Each facility in Vietnam uses the Ministry of Health guidelines for pricing different drugs to create its unique offerings. These costs are up to six times higher than in world markets. Procurement of brand-name drugs versus generics affects facility spending in Vietnam and, therefore, affects individuals and/or the insurance system.

In Vietnam, diabetes is considered a public health burden, and public health officials have taken steps to reduce this burden. Various trends and epidemiological factors influence the burden of diabetes in Vietnam. Diabetes poses a significant threat and has the potential to become a widespread issue, placing a substantial burden on both the health and economy of Vietnam. While the prevalence of diabetes in rural areas has been relatively low, it is gradually increasing. Notably, diabetes is as prevalent in major cities of Vietnam as it is in other parts of the Western world.

Vietnam Insulin Infusion Pump Industry Segmentation

An insulin pump delivers insulin to control blood sugar and minimize hypoglycemia's effects. The pump comprises a pump reservoir like an insulin cartridge, a battery-operated pump, and a computer chip that allows the user to control the exact amount of insulin being delivered. The pump is attached to a thin plastic tube (an infusion set) with a soft cannula (or needle) at the end through which insulin passes. Vietnam's insulin infusion pumps market is segmented by component (pump device, infusion set, and reservoir). The report offers the value (USD) and Volume (units) for the above segments.